Astaxanthin Ester Bioproduction Engineering Service

Astaxanthin Ester (Asta-ester) is the most stable and bioavailable form of the powerful antioxidant Astaxanthin, widely used in aquaculture feed (for pigmenting fish and shrimp) and high-end cosmetics. Traditional production using the microalga Haematococcus pluvialis suffers from a long cultivation cycle , requiring days to weeks for the cells to accumulate sufficient astaxanthin under stress, making production slow and volume-limited. Moreover, free Astaxanthin, the precursor, exhibits poor stability against oxidation, light, and heat, complicating downstream handling. Biosynthesis in engineered yeast offers a fast, controllable, and stable production route.

CD Biosynsis offers a synthetic biology service focused on highly efficient Asta-ester production in Saccharomyces cerevisiae. Our core strategy involves modification of astaxanthin synthesis pathway in Saccharomyces cerevisiae . We engineer the yeast host by introducing and optimizing the bacterial or microalgal gene cluster (CrtE, CrtB, CrtI, CrtY, CrtZ, CrtW) necessary to convert endogenous IPP precursors into Astaxanthin. Crucially, this pathway is tuned to maximize flux. This is coupled with directed evolution of ester synthase . We introduce a specific Astaxanthin Acyltransferase (ester synthase) enzyme to perform the final stabilization step. This enzyme is then subjected to directed evolution (e.g., error-prone PCR and high-throughput screening) to enhance its activity, substrate specificity, and thermal stability, ensuring rapid and complete conversion of free Astaxanthin into the highly stable Asta-ester. This integrated approach aims to deliver a high-titer, high-purity, and intrinsically stable Asta-ester product from a simple glucose feedstock, eliminating the time and cost associated with algal cultivation.

Pain Points

Developing a competitive Asta-ester production route faces these key challenges:

• Long Cultivation Cycle for Haematococcus pluvialis: The algae must be subjected to stress (e.g., nitrogen starvation, high light) to induce Astaxanthin accumulation, resulting in slow batch times and high labor/energy costs.
• Poor Stability: Free Astaxanthin is chemically vulnerable due to its polyene structure, leading to rapid degradation under processing conditions, resulting in product loss.
• Rate-Limiting Precursor Supply: The native MVA (Mevalonate) pathway in yeast is heavily regulated, leading to a bottleneck in the supply of IPP and DMAPP precursors for carotenoid synthesis.
• Low Esterification Efficiency: The introduced ester synthase may exhibit low specific activity or poor affinity for the Astaxanthin substrate, leading to incomplete conversion and a mixture of free Astaxanthin and mono-/di-esters.

A successful solution must significantly accelerate the production rate while ensuring the final product is delivered in its most stable form.

Solutions

CD Biosynsis utilizes advanced metabolic and enzyme engineering to optimize Asta-ester production in S. cerevisiae:

Modification of Astaxanthin Synthesis Pathway in S. cerevisiae

           

We engineer the MVA pathway for enhanced IPP supply and introduce the complete Astaxanthin synthesis gene cluster (CrtE, CrtB, CrtI, CrtY, CrtZ, CrtW) with balanced expression levels.

Directed Evolution of Ester Synthase

We use directed evolution techniques (e.g., site-saturation mutagenesis, DNA shuffling) to evolve the Astaxanthin Acyltransferase for improved catalytic efficiency and higher conversion rate to the desired diester form.

Subcellular Localization Optimization

We target the synthesis enzymes and the ester synthase to the yeast lipid droplets , which serve as the native synthesis site and sink for high-concentration carotenoid accumulation, mitigating toxicity.

Codon Optimization and Gene Balancing

All heterologous genes are codon-optimized for S. cerevisiae and their expression levels are fine-tuned using a library of promoters and terminators to prevent bottlenecks.

This systematic approach focuses on establishing a highly efficient pathway and maximizing the stability of the final product through enzymatic perfection.

Advantages

Our Asta-ester engineering service is dedicated to pursuing the following production goals:

Dramatically Reduced Production Cycle

Fermentation is completed in days, compared to weeks for algae, significantly lowering operating expenses and improving throughput.

Superior Product Stability

The esterified form has enhanced resistance to environmental stress , maintaining its potency during processing and storage.

High Conversion Efficiency

Directed evolution ensures the ester synthase efficiently converts all free Astaxanthin to the desired ester form.

GMP Compatibility

S. cerevisiae is a well-established food-grade host (GRAS), making it easily transferable to cGMP manufacturing environments.

Controlled Output Profile

Unlike algae, biosynthesis allows for a precise, consistent mixture of mono- and di-esters (Asta-ester), which is critical for formulation.

We provide a sustainable and cost-effective biosynthetic platform for industrial Astaxanthin Ester production.

Process

Our Asta-ester strain engineering service follows a rigorous, multi-stage research workflow:

• MVA Pathway Enhancement: Overexpress the rate-limiting steps (e.g., HMG-CoA reductase) in the yeast MVA pathway to maximize precursor supply.
• Astaxanthin Cluster Assembly: Integrate and balance the expression of the six Crt genes necessary for conversion of IPP to Astaxanthin (CrtE, B, I, Y, Z, W).
• Directed Evolution of Acyltransferase: Create a library of Astaxanthin Acyltransferase mutants and use high-throughput screening to isolate variants with the highest esterification activity and stability.
• Subcellular Targeting: Employ specific targeting sequences to localize the synthesis and esterification enzymes to the lipid droplet membrane for optimal function.
• Fermentation Performance Validation: Test the final engineered strain in fed-batch fermentation to assess Asta-ester titer, yield, and ester profile (mono /di ratio).
• Result Report Output: Compile a detailed Experimental Report including gene modification data, enzyme evolution results, and fermentation metrics (yield, titer, and stability) , supporting commercial scale-up.

Technical communication is maintained throughout the process, focusing on timely feedback regarding yield and esterification completeness.

Explore the potential for a high-stability, sustainable Astaxanthin Ester supply. CD Biosynsis provides customized strain and enzyme engineering solutions:

• Detailed Esterification Efficiency Report , demonstrating the complete conversion of free Astaxanthin to the esterified forms.
• Consultation on optimized cell disruption and solvent extraction protocols for efficient Asta-ester recovery from yeast biomass.
• Experimental reports include complete raw data on volumetric titer (g/L) and product stability under accelerated shelf-life tests.